People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Business Services, Other Technology, Fintech, Other, Software / Tech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AvidXchange, Inc. | — | Business Services | Series D+ | $1.1B | $106.9M | 2015 |
| Justworks, Inc. | — | Other Technology | Series C | $130.4M | $198.1M | 2018 |
| Txvia Inc | — | Other Technology | Series B | $52.1M | $837.5M | 2009 |
| Bloom Credit, Inc | — | Fintech | Series A | $21.4M | $15.0M | 2017 |
| Zelis Parent, L.P. | — | Other | Series B | $20.5M | $339.9M | 2020 |
| Simple Finance Technology Corp | — | Other Technology | Series A | $11.4M | $62.7M | 2013 |
| Driving Management Systems, Inc. | — | Software / Tech | Seed | $8.8M | $67.8M | 2020 |
| Vico Software Inc | — | Other Technology | Seed | $3.6M | $121.8M | 2009 |
| Active Life Scientific, Inc. | — | Other Health Care | Seed | $2.8M | $23.5M | 2016 |
Matt Harris at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matt Harris on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew Harris | 3 | 13 |
| Brad Feld | 1 | 29 |
| Roger Ehrenberg | 1 | 14 |
| Spencer Tall | 1 | 12 |
| Mark Goines | 1 | 11 |
| Bradley Svrluga | 1 | 9 |
| Nigel Morris | 1 | 9 |
| James Anderson | 1 | 8 |
| Dan Rosen | 1 | 8 |
| Gerard Neumann | 1 | 6 |
| Jesse Devitte | 1 | 6 |
| DAVID HUMPHREY | 1 | 6 |
| Mark Murray | 1 | 4 |
| Davis Brimer | 1 | 3 |
| Jared Weinstein | 1 | 3 |
| Hans Morris | 1 | 3 |
| Mark Sawyer | 1 | 3 |
| Steve McLaughlin | 1 | 3 |
| Anil Aggarwal | 1 | 3 |
| Robert Chevlin | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.